GEORGETOWN LOMBARDI Comprehensive Cancer Center and John Theurer Cancer Center, part of Hackensack University Medical Center, developed a joint cancer research agenda as part of a multi-year plan to form a NCI-recognized cancer consortium.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
